IONQ
IONQ
$38.88
-9.29%
IonQ, Inc. is a quantum computing company that provides access to its quantum computers via cloud platforms and quantum-computing-as-a-service (QCaaS), operating in the emerging quantum computing industry. As a pure-play leader in trapped-ion quantum computing, IonQ distinguishes itself through its cloud-based approach and ongoing research into higher-capacity quantum systems. The current investor narrative centers on the company's path to commercial viability amid a 40% decline from all-time highs, with attention focused on government funding catalysts, insider selling concerns, and the need to secure funding to sustain operations through 2028.…
IONQ
IONQ
$38.88
Related headlines
Investment Opinion: Should I buy IONQ Today?
Rating: Hold. Thesis: IonQ is a high-risk, high-reward speculative stock with strong revenue growth and a solid balance sheet, but extreme valuation and lack of profitability warrant caution. The analyst consensus is Buy (3 analysts), but without a consensus price target, the upside is uncertain.
Supporting Evidence: Revenue grew 428.5% YoY in Q4 2025 to $61.89M, and gross margins improved from 9.9% to 56.5%. The forward PS of 9.7x (based on $1.29B estimated revenue) is more reasonable than the trailing 96.75x, but still implies aggressive expectations. The company has $1.04B in cash and no debt, providing a strong liquidity buffer. However, operating losses remain deep at -392.2% margin, and free cash flow is negative.
Risks & Conditions: The Hold rating would upgrade to Buy if the stock pulls back to $25 (52-week low) or if revenue growth consistently exceeds 100% YoY with improving margins. It would downgrade to Sell if insider selling accelerates or if the company announces a dilutive equity offering. Valuation verdict: IonQ is overvalued relative to its history and peers on a trailing basis, but fairly valued on a forward PS basis if it achieves the $1.29B revenue estimate.
Sign up to view all
IONQ 12-Month Price Forecast
IonQ is at a critical juncture where its extreme valuation must be justified by sustained high growth. The base case of $35-55 is most likely, given the lumpy revenue and high expectations. The bull case requires a step-change in commercial adoption, while the bear case could materialize if growth disappoints. The neutral stance reflects balanced risk/reward, with a slight bearish tilt due to insider selling and valuation concerns. An upgrade to bullish would require consistent revenue beats and margin improvement; a downgrade to bearish would follow a significant miss or dilutive financing.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IONQ's 12-month outlook, with a consensus price target around $50.54 and implied upside of +30.0% versus the current price.
Average Target
$50.54
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$31 - $51
Analyst target range
Insufficient analyst coverage available. Only 3 analysts cover IonQ, with a consensus that leans bullish (Buy ratings from Benchmark, Craig-Hallum, and Needham, while Goldman Sachs and Morgan Stanley rate it Neutral/Equal Weight). The average EPS estimate is -$1.48, with a range from -$2.01 to -$1.29, and average revenue estimate of $1.29 billion for the next fiscal year. The limited coverage means the stock may experience higher volatility and less efficient price discovery, as fewer analysts provide earnings estimates and price targets. The wide EPS range ($0.72 spread) indicates significant uncertainty about the company's path to profitability. Without a consensus price target, investors must rely on qualitative factors and technical levels for valuation guidance.
Bulls vs Bears: IONQ Investment Factors
IonQ presents a high-risk, high-reward opportunity. The bull case rests on accelerating revenue growth, improving gross margins, a strong cash position, and government funding catalysts. The bear case highlights extreme valuation, heavy operating losses, insider selling, and revenue lumpiness. Currently, the bear case has stronger evidence given the 96.75x trailing PS ratio and lack of profitability, but the bull case could prevail if revenue growth sustains above 100% YoY and margins continue to improve. The single most important tension is whether IonQ can convert its technological leadership into consistent, scalable revenue before its cash runway runs out or dilution erodes shareholder value.
Bullish
- Revenue Growth Acceleration: Q4 2025 revenue surged 428.5% YoY to $61.89M, driven by large contract wins. This demonstrates strong commercial traction and the potential for exponential revenue scaling as quantum computing adoption increases.
- Improving Gross Margins: Gross margin improved from 9.9% in Q4 2024 to 56.5% in Q4 2025, indicating significant scaling efficiencies. This trend suggests the business model is becoming more profitable at the unit level.
- Strong Balance Sheet: IonQ holds $1.04B in cash with virtually no debt (debt-to-equity of 0.008). This provides a multi-year runway to fund operations and R&D without immediate financing pressure.
- Government Funding Catalyst: Recent $2B federal funding announcement for quantum computing and direct government equity investments create a sovereign-backed capital runway. IonQ is well-positioned to benefit as a domestic leader.
Bearish
- Extreme Valuation Premium: Trailing PS ratio of 96.75x is astronomical compared to any traditional hardware or software company. Even the forward PS of 9.7x implies massive revenue growth that may not materialize, leaving the stock vulnerable to multiple compression.
- Heavy Operating Losses: Operating margin was -392.2% in Q4 2025, with R&D spending of $96.1M alone exceeding revenue. The company is far from profitability, and continued losses could erode investor confidence.
- Insider Selling Red Flag: Insiders have sold $857M in stock over two years with virtually no buying. This signals a lack of confidence from those closest to the business and could presage further dilution or negative news.
- Revenue Lumpiness and Deceleration: Q4 2025 revenue of $61.89M was a spike, but Q3 was $39.87M and Q2 was $20.69M, showing sequential deceleration. Dependence on large, infrequent contracts makes revenue unpredictable.
IONQ Technical Analysis
IonQ's 1-year price change of -6.68% masks a volatile journey, with the stock currently trading at $42.86, representing 50.6% of its 52-week range ($25.89 to $84.64). This positioning near the midpoint suggests the stock is in a consolidation phase after a significant rally and subsequent pullback, lacking clear directional conviction. The 52-week low of $25.89 provides a critical support level, while the high of $84.64 marks formidable resistance. Over the past 3 months, the stock surged 48.87%, but the 1-month change of -24.32% indicates a sharp reversal of that momentum. This divergence—strong medium-term gains followed by recent weakness—could signal a temporary pullback within a broader uptrend or the start of a more sustained decline. The beta of 3.23 confirms extreme volatility, amplifying market moves by over 3x. The current price sits 49.4% below the 52-week high, suggesting the stock is not overextended to the upside, but the rapid 1-month decline warrants caution. A break above $84.64 would signal a resumption of the long-term uptrend, while a fall below $25.89 would indicate a breakdown and potential further downside. The high beta means the stock is highly sensitive to market sentiment, and position sizing should account for this elevated risk.
Beta
3.23
3.23x market volatility
Max Drawdown
-67.6%
Largest decline past year
52-Week Range
$26-$85
Price range past year
Annual Return
-7.0%
Cumulative gain past year
| Period | IONQ Return | S&P 500 |
|---|---|---|
| 1m | -32.8% | +1.0% |
| 3m | +8.7% | +7.9% |
| 6m | -23.6% | +8.5% |
| 1y | -7.0% | +20.1% |
| ytd | -16.9% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IONQ Fundamental Analysis
IonQ's revenue trajectory shows strong growth, with Q4 2025 revenue of $61.89 million representing a 428.5% year-over-year increase from $11.71 million in Q4 2024. However, this growth is lumpy and driven by large contract wins; Q3 2025 revenue was $39.87 million, and Q2 2025 was $20.69 million, indicating sequential deceleration from Q4's peak. The company remains pre-profitability, with a net loss of $703.5 million in Q4 2025, though this includes significant non-cash items. Gross margin improved dramatically to 56.5% in Q4 2025 from 9.9% in Q4 2024, signaling scaling efficiencies. Operating margin remains deeply negative at -392.2% in Q4 2025, reflecting heavy R&D spending ($96.1 million in Q4 alone) and SG&A costs. The company is not yet profitable on an operating basis, but the narrowing of operating losses as a percentage of revenue is a positive sign. IonQ's balance sheet is strong, with $1.04 billion in cash at the end of Q4 2025 and virtually no debt (debt-to-equity ratio of 0.008). Free cash flow was negative $83.3 million in Q4 2025, but the company has ample liquidity to fund operations. ROE was 18.5% in Q4 2025, driven by the large net income figure (which includes non-operating gains), but normalized ROE remains negative. The current ratio of 15.5 indicates excellent short-term liquidity, though the reliance on equity financing (common stock issued of $1.95 billion in Q4 2025) highlights ongoing dilution risk.
Quarterly Revenue
$61890000.0B
2025-12
Revenue YoY Growth
+428.52%
YoY Comparison
Gross Margin
56.48%
Latest Quarter
Free Cash Flow
$-301797000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IONQ Overvalued?
Given that IonQ has negative net income (EPS of -$0.04), the price-to-sales (PS) ratio is the most appropriate valuation metric. The trailing PS ratio is 96.75x, while forward PS (based on estimated revenue of $1.29 billion) is approximately 9.7x, implying the market expects massive revenue growth. The wide gap between trailing and forward PS reflects aggressive growth expectations embedded in the current price. Compared to the industry average PS ratio (data not available), IonQ trades at a significant premium to any traditional hardware or software company, reflecting its status as a pure-play quantum computing leader with high growth potential. Historically, IonQ's PS ratio has ranged from extreme levels (over 20,000x in early 2021) to current levels around 97x. The current PS is near the lower end of its historical range, suggesting that while still expensive in absolute terms, the multiple has compressed significantly from earlier peaks. This compression could indicate that the market is pricing in more realistic growth expectations, but the stock remains highly speculative and sensitive to revenue delivery.
PE
-24.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -148x~6x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-24.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: IonQ's primary financial risk is its heavy reliance on equity financing, with $1.95B in common stock issued in Q4 2025 alone, causing significant dilution. The company is not profitable, with an operating margin of -392.2% and negative free cash flow of $83.3M in Q4 2025. While $1.04B in cash provides a runway, the cash burn rate of ~$300M annually means the company must either achieve profitability or secure additional funding by 2028. Revenue concentration is also a risk, as Q4 2025's $61.89M spike was driven by large contracts, and sequential revenue deceleration from Q4 to Q1 2026 (implied by analyst estimates) could signal lumpiness.
Market & Competitive Risks: The stock trades at a trailing PS of 96.75x, a massive premium to any traditional tech company, making it vulnerable to valuation compression if growth disappoints. With a beta of 3.23, IonQ is highly sensitive to macro conditions and sector rotation out of speculative growth stocks. The quantum computing space is becoming increasingly competitive, with Quantinuum's IPO and well-capitalized players like IBM and Google. Recent insider selling of $857M over two years is a major red flag, suggesting those closest to the company see limited upside at current levels.
Worst-Case Scenario: If IonQ fails to secure additional government contracts or commercial revenue falls short of the $1.29B consensus, the stock could re-rate to a PS multiple more in line with pre-revenue quantum peers (e.g., 20-30x trailing). This would imply a price of $10-15, representing a -65% to -77% decline from the current $42.86. The 52-week low of $25.89 provides a near-term floor, but a break below that could trigger a slide to $15, the level seen in early 2024. In this scenario, an investor could lose up to 77% of their investment.
FAQ
The key risks are: 1) Valuation risk — trailing PS of 96.75x leaves little room for error; a growth miss could trigger a severe multiple compression. 2) Financial risk — the company is unprofitable with an operating margin of -392.2% and negative free cash flow of $83.3M in Q4 2025; dilution risk is high as the company may need to issue more stock. 3) Competitive risk — the quantum computing space is becoming crowded with well-funded players like Quantinuum, IBM, and Google. 4) Insider selling risk — insiders have sold $857M in stock over two years with no buying, signaling lack of confidence. The most severe risk is a combination of revenue disappointment and dilution, which could drive the stock below $15.
The 12-month outlook is mixed: the base case (50% probability) sees the stock trading between $35 and $55, driven by revenue growth in line with the $1.29B consensus. The bull case (20% probability) targets $65-$85, fueled by major contract wins and quantum breakthroughs. The bear case (30% probability) sees the stock falling to $15-$30 if growth disappoints or competitive pressures intensify. The most likely scenario is the base case, assuming IonQ can sustain revenue growth of ~100% YoY and maintain gross margins above 50%. However, the high volatility (beta 3.23) means actual outcomes could deviate significantly.
IonQ is overvalued on a trailing basis with a PS ratio of 96.75x, but appears more reasonably valued on a forward PS of ~9.7x based on estimated revenue of $1.29B. Compared to the industry average (not available), it trades at a significant premium to any traditional hardware or software company. Historically, the PS ratio has compressed from over 20,000x in early 2021 to current levels, suggesting the market is pricing in more realistic expectations. However, the forward multiple still implies massive growth, and if revenue falls short, the stock could be considered overvalued. The valuation implies the market expects IonQ to become a dominant player in quantum computing with billions in revenue.
IonQ is a high-risk, high-reward stock that could be a good buy for aggressive investors with a long-term horizon and high risk tolerance. The company has strong revenue growth (428.5% YoY in Q4 2025), improving gross margins (56.5%), and a solid balance sheet ($1.04B cash, no debt). However, the trailing PS ratio of 96.75x is extremely expensive, and the company is not profitable, with an operating margin of -392.2%. The biggest downside risk is valuation compression if growth disappoints, which could lead to a -65% decline. For risk-averse investors, it is not a good buy; for those willing to accept high volatility, it may be worth a small position if they believe in quantum computing's long-term potential.
IonQ is more suitable for long-term investment (5+ years) given its early-stage nature and the long timeline for quantum computing commercialization. The company is pre-profitability and has a high cash burn rate, but its strong balance sheet provides a runway to 2028. Short-term trading is extremely risky due to the stock's beta of 3.23 and high volatility; the 1-month decline of -24.32% illustrates the potential for sharp losses. For long-term investors, the key is to monitor revenue growth and margin improvement; a minimum holding period of 3-5 years is recommended to allow the quantum computing market to develop. The stock pays no dividend, so total return depends entirely on price appreciation.